期刊
MICROORGANISMS
卷 8, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/microorganisms8122035
关键词
carbapenem resistant; Klebsiella pneumoniae; bacteriuria; antimicrobial therapy; critically ill
类别
资金
- Taipei Veterans General Hospital [V103B-016, V104B-001, V105B-001, V106B-001, V107C-081]
- Ministry of Science and Technology in Taiwan [MOST 105-2628-B-010-015-MY3, MOST 108-2314-B-010 -030 -MY3]
- Centers for Disease Control, R.O.C. (Taiwan) [DOH101-DC-1204, DOH102-DC-1508, MOHW103-CDC-C-114-134504, MOHW104-CDC-C-114-144406]
Few clinical studies have previously discussed patients with carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria. This study aimed to assess the effect of antimicrobial therapy on the mortality of patients with CRKP bacteriuria. Hospitalized adults with CRKP bacteriuria were enrolled retrospectively from 16 hospitals in Taiwan during 2013 and 2014. Critically ill patients were defined as those with an Acute Physiology and Chronic Health Evaluation (APACHE) II score >= 20. Multivariate Cox regression analysis was used to determine independent risk factors for 14- and 28-day mortality. Of 107 patients with CRKP bacteriuria, the 14-day and 28-day mortality was 14.0% and 25.2%, respectively. Thirty-three patients received appropriate antimicrobial therapy. In the multivariate Cox regression analysis, the APACHE II score >= 20 was the only independent risk factor for 14-day mortality (hazard ratio [HR]: 6.15, p = 0.024). APACHE II score >= 20 (HR: 3.05, p = 0.018) and male sex (HR: 2.57, p = 0.037) were associated with 28-day mortality. Among critically ill patients with CRKP bacteriuria, appropriate antimicrobial therapy was not associated with 14-day or 28-day survival. In conclusion, in patients with CRKP bacteriuria, the use of appropriate antimicrobial therapy was not an independent factor associated with reduced mortality. Our findings may inform future antibiotic stewardship interventions for bacteriuria caused by multidrug resistant pathogens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据